Alcidion Group Ltd
ALC.AU
Exchange: | AU |
Currency | Australian Dollar |
Open Figi: | BBG001P0XB53 |
ISIN: | AU000000ALC6 |
Fiscal Year End: | June |
International Domestic: | International |
Sector: | Healthcare |
Industry: | Health Information Services |
Gic Sector: | Health Care |
Gic Group: | Health Care Equipment & Services |
Gic Industry: | Health Care Technology |
Gic Sub Industry: | Health Care Technology |
Description: | Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and Extra Med, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia. |
Address: | 9 Yarra Street, South Yarra, VIC, Australia, 3141 |
Website: | https://www.alcidion.com |
Full Time Employees: | 191 |
Updated On: | 2024-04-02 |
Highlights
Market Capitalization: | 64438560 |
Market Capitalization Mln: | 64.43 |
EBITDA: | -6154000 |
Wall Street Target Price: | 0.08 |
Book Value: | 0.06 |
Most Recent Quarter: | 2023-12-31 |
Profit Margin: | -0.12 |
Operating Margin TTM: | -0.23 |
Return On Assets TTM: | -0.03 |
Return On Equity TTM: | -0.05 |
Revenue TTM: | 40475000 |
Revenue Per Share TTM: | 0.03 |
Gross Profit TTM: | 34771000 |
Valuation
Forward PE: | 43.29 |
Price Sales TTM: | 1.59 |
Price Book MRQ: | 0.69 |
Enterprise Value: | 57257241 |
Enterprise Value Revenue: | 1.41 |
Enterprise Value Ebitda: | -18.07 |
Shares
Shares Outstanding: | 1342470016 |
Shares Float: | 946376497 |
Percent Insiders: | 32.45 |
Percent Institutions: | 12.20 |
Technicals
Beta: | 1.35 |
52 Week High: | 0.13 |
52 Week Low: | 0.04 |
50 Day MA: | 0.05 |
200 Day MA: | 0.08 |
Earnings
Report Date: | 2025-02-20 |
Date: | 2024-12-31 |
Before After Market: | After Market |
Currency: | AUD |
Report Date: | 2024-07-25 |
Date: | 2024-06-30 |
Before After Market: | After Market |
Currency: | AUD |
Report Date: | 2023-02-24 |
Date: | 2022-12-31 |
Before After Market: | Before Market |
Currency: | AUD |
Report Date: | 2022-08-30 |
Date: | 2022-06-30 |
Before After Market: | Before Market |
Currency: | AUD |
Report Date: | 2022-02-23 |
Date: | 2021-12-31 |
Before After Market: | Before Market |
Currency: | AUD |
Eps Actual: | -0.01 |
Eps Difference: | -0.01 |
Report Date: | 2021-08-24 |
Date: | 2021-06-30 |
Before After Market: | Before Market |
Currency: | AUD |
Report Date: | 2021-02-25 |
Date: | 2020-12-31 |
Before After Market: | Before Market |
Currency: | AUD |
Report Date: | 2020-08-27 |
Date: | 2020-06-30 |
Before After Market: | After Market |
Currency: | AUD |
Report Date: | 2020-02-24 |
Date: | 2019-12-31 |
Currency: | AUD |
Report Date: | 2019-08-28 |
Date: | 2019-06-30 |
Currency: | AUD |
Report Date: | 2019-02-24 |
Date: | 2018-12-31 |
Currency: | AUD |
Report Date: | 2018-08-30 |
Date: | 2018-06-30 |
Currency: | AUD |
Report Date: | 2018-02-27 |
Date: | 2017-12-31 |
Currency: | AUD |
Report Date: | 2017-09-29 |
Date: | 2017-06-30 |
Currency: | AUD |
Report Date: | 2017-02-28 |
Date: | 2016-12-31 |
Currency: | AUD |
Report Date: | 2016-09-30 |
Date: | 2016-06-30 |
Currency: | AUD |
Report Date: | 2016-02-22 |
Date: | 2015-12-31 |
Currency: | AUD |
Date: | 2025-06-30 |
Period: | +1y |
Earnings Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Avg: | 41430000.00 |
Revenue Estimate Low: | 38100000.00 |
Revenue Estimate High: | 44000000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.07 |
Date: | 2024-06-30 |
Earnings Estimate Low: | -0.01 |
Earnings Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Avg: | 38700000.00 |
Revenue Estimate Low: | 37900000.00 |
Revenue Estimate High: | 39600000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | -0.04 |
Date: | 2024-03-31 |
Date: | 2023-12-31 |
Date: | 2023-09-30 |
Revenue Estimate Avg: | 38980000.00 |
Revenue Estimate Low: | 38000000.00 |
Revenue Estimate High: | 39700000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.13 |
Date: | 2023-06-30 |
Earnings Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Avg: | 39230000.00 |
Revenue Estimate Low: | 38000000.00 |
Revenue Estimate High: | 40000000.00 |
Revenue Estimate Number Of Analysts: | 3.00 |
Revenue Estimate Growth: | 0.14 |
Eps Revisions Up Last7days: | 1.00 |
Eps Revisions Up Last30days: | 1.00 |
Date: | 2023-03-31 |
Date: | 2022-12-31 |
Date: | 2022-09-30 |
Revenue Estimate Avg: | 34000000.00 |
Revenue Estimate Low: | 34000000.00 |
Revenue Estimate High: | 34000000.00 |
Revenue Estimate Number Of Analysts: | 1.00 |
Revenue Estimate Growth: | 0.31 |
Date: | 2022-06-30 |
Earnings Estimate Number Of Analysts: | 1.00 |
Revenue Estimate Avg: | 34000000.00 |
Revenue Estimate Low: | 34000000.00 |
Revenue Estimate High: | 34000000.00 |
Revenue Estimate Number Of Analysts: | 1.00 |
Revenue Estimate Growth: | 0.31 |
Date: | 2022-03-31 |
Date: | 2021-12-31 |
Date: | 2021-09-30 |
Period: | +1q |
Date: | 2021-06-30 |
Revenue Estimate Avg: | 39000000.00 |
Revenue Estimate Low: | 39000000.00 |
Revenue Estimate High: | 39000000.00 |
Revenue Estimate Number Of Analysts: | 1.00 |
Revenue Estimate Growth: | 0.50 |
Date: | 2022-12-31 |
Date: | 2022-06-30 |
Eps Actual: | -0.0 |
Date: | 2021-06-30 |
Date: | 2020-06-30 |
Date: | 2019-06-30 |
Date: | 2018-06-30 |
Date: | 2017-06-30 |
Date: | 2016-06-30 |